R1 Therapeutics is utilizing expert guidance for its AP306 Phase 2b clinical trials, involving Stanford University School of Medicine.
2 reports, 1 independent
Updated Jul 1
Gone quiet
- Reports
- 2
- Developments
- 1
- Repetition
- 50%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
R1 Therapeutics is utilizing expert guidance for its AP306 Phase 2b clinical trials, involving Stanford University School of Medicine.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Stanford University School of Medicine
medical school of Stanford University in California
Nothing else this week.